Comparison

Kanamycin (sulfate) European Partner

Item no. HY-16566A-5g
Manufacturer MedChem Express
CASRN 25389-94-0
Amount 5 g
Quantity options 10 mM/1 mL 1 g 200 mg 5 g
Category
Type Inhibitors
Specific against other
Purity 99.96
Citations [1]YANAGISAWA K, et al. Studies on kanamycin, a new antibiotic against tubercle bacilli. I. Effect on virulent tubercle bacilli in vitro and in mice. J Antibiot (Tokyo). 1957 Nov;10(6):233-5. |[2]Nishi T, et al. Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin. Antimicrob Agents Chemother. 1980 Mar;17(3):494-505. |[3]Misumi M, et al. Interaction of kanamycin and related antibiotics with the large subunit of ribosomes and the inhibition of translocation. Biochem Biophys Res Commun. 1978 Sep 29;84(2):358-65.|[4]Misumi M, et al. Mechanism of inhibition of translocation by kanamycin and viomycin: a comparative study with fusidic acid. Biochem Biophys Res Commun. 1980 Jan 29;92(2):647-54.
ACS Chem Biol. 2021 Dec 15.|ACS Infect Dis. 2024 Apr 12;10(4):1327-1338.|Cell Death Dis. 2021 May 18;12(6):509.|Int J Hydrogen Energy. 2018, 43(30), 13821-13828.|Microb Biotechnol. 2021 Mar 15.|Nucleic Acids Res. 2022 Dec 12;gkac1141.|Sci Adv. 2023 Feb 17;9(7):eade4770.|Adv Sci (Weinh). 2024 Jun 21.|AMB Express. 2024 Dec 24;14(1):141.|Aquat Toxicol. 2025 Feb 9:280:107284.|bioRxiv. 2025 January 19.|Food Chem. 2022 Sep 26;403:134399.|Int J Med Microbiol. 2023 Mar 28;313(2):151578.|J Periodontol. 2024 Jul 4.|Vet Res Commun. 2024 Sep 26.
Smiles OS(O)(=O)=O.O[C@H]1[C@](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)([H])O[C@H](CN)[C@@H](O)[C@@H]1O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Kanamycin A (sulfate)
Shipping Condition Room temperature
Available
Manufacturer - Type
Natural Products
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
Antibiotic; Bacterial
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Molecular Weight
582.58
Product Description
Kanamycin (Kanamycin A) sulfate is an orally active antibacterial (gram-negative/positive bacteria) agent, inhibits translocation and causes misencoding by binding to the 70 S ribosomal subunit. Kanamycin sulfate shows good inhibitory activity to both M. tuberculosis (sensitive and drug-resistant ) and K. pneumonia, which can be used in studies of tuberculosis and pneumonia[1][2][3][4].
Manufacturer - Research Area
Infection
Solubility
DMSO: < 1 mg/mL|H2O: ≥ 25 mg/mL
Manufacturer - Pathway
Anti-infection
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 g
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close